7 research outputs found

    Killing Adherent and Nonadherent Cancer Cells with the Plasma Pencil

    Get PDF
    The application of low temperature plasmas in biology and medicine may lead to a paradigm shift in the way various diseases can be treated without serious side effects. Low temperature plasmas generated in gas mixtures that contain oxygen or air produce several chemically reactive species that have important biological implications when they interact with eukaryotic or prokaryotic cells. Here, a review of the effects of low temperature plasma generated by the plasma pencil on different cancerous cells is presented. Results indicate that plasma consistently shows a delayed killing effect that is dose dependent. In addition, there is some evidence that apoptosis is one of the pathways that leads to the death of the cells,indicating that plasma initiates cell signaling pathways

    A Review of Phage Therapy Against Bacterial Pathogens of Aquatic and Terrestrial Organisms

    Get PDF
    Since the discovery of bacteriophage in the early 1900s, there have been numerous attempts to exploit their innate ability to kill bacteria. The purpose of this report is to review current findings and new developments in phage therapy with an emphasis on bacterial diseases of marine organisms, humans, and plants. The body of evidence includes data from studies investigating bacteriophage in marine and land environments as modern antimicrobial agents against harmful bacteria. The goal of this paper is to present an overview of the topic of phage therapy, the use of phage-derived protein therapy, and the hosts that bacteriophage are currently being used against, with an emphasis on the uses of bacteriophage against marine, human, animal and plant pathogens

    Plasma processes and polymers third special issue on plasma and cancer

    Get PDF
    (First paragraph) This issue of Plasma Processes and Polymers is the third in a series on the applications of low temperature plasma (LTP) against cancer, or “plasma oncology.” The papers in this issue are inspired from the talks given at the third International Workshop on Plasma for Cancer Treatment (IWPCT) which took place on April 11–12, 2016 in Washington, DC, USA. IWPCT is an international workshop that was created in 2014 as a venue to share cutting edge plasma oncology research. The first IWPCT was held in Washington DC, under the co-chairmanship of Prof. Mounir Laroussi (Old Dominion University) and Prof. Michael Keidar (George Washington University). The second workshop, IWPCT-2, was held in March 2015 in Nagoya, Japan under the chairmanship of Prof. Masaru Hori (Nagoya University). As mentioned above, IWPCT-3 was held again in Washington DC in 2016 under the co-chairmanship of Dr. Jerome Canady (Jerome Canady Research Institute) and Dr. Jonathan Sherman (George Washington University)
    corecore